Featured Research

from universities, journals, and other organizations

Advantages of standardizing diabetes treatments

Date:
July 8, 2014
Source:
Investigación y Desarrollo
Summary:
Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition of the person.

Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition of the person.

Related Articles


All guides propose that from the moment diabetes is diagnosed, the patient should diet combined with exercise, and start taking metformin, which is the "standard prescription" of all international and national guidelines, said Rutila Castañeda Limones endocrinology specialist and researcher at the "Mexico Center for Clinical Research."

In Mexico, the guides are used in all public and private medical institutions, the Mexican Social Security Institute (IMSS) has the lead, although the Mexican Official Standard is supported by the proposals of the international organizations, which are based on European and American standards.

Metformin helps the patient lose weight, improves the biological effect of the administered insulin, reduces cardiovascular risk and osteoporosis, plus it's the cheapest drug for diabetics on the market.

As a second option therapeutic, medical guides explain that if this drug were to decompensate the patient a combined treatment should be given, taking metformin as a base, since virtually all metabolic alterations caused by diabetes are covered.

The advantage of metformin is that it can be combined with other drugs, such as GLP-1 or insulin. Potentiating the treatment and minimizing side effects.

Castañeda Limones said that although there are many options on the market for metformin, not all have the same response in patients, so the doctor and patient must give timely follow ups.

There are options for quick and prolonged release, which will be administered according to patient characteristics. For example, using extended release metformin as the presentation by Merck pharmaceuticals, which was recently launched in Mexico, helps to reduce side effects in the patient, explained the specialist in endocrinology.

Medical guides focus on patient characteristics, according to age, family conditions, if you have a support network, or associated diseases. Endocrinologists should determine the best possible treatment.

"If a patient has hypertension, obesity, overweight, cardiovascular damage, there is greater difficulty in achieving adequate treatment and is therefore more difficult to take it to the goals of excellence," said the specialist in endocrinology and nutrition.


Story Source:

The above story is based on materials provided by Investigación y Desarrollo. Note: Materials may be edited for content and length.


Cite This Page:

Investigación y Desarrollo. "Advantages of standardizing diabetes treatments." ScienceDaily. ScienceDaily, 8 July 2014. <www.sciencedaily.com/releases/2014/07/140708092126.htm>.
Investigación y Desarrollo. (2014, July 8). Advantages of standardizing diabetes treatments. ScienceDaily. Retrieved October 25, 2014 from www.sciencedaily.com/releases/2014/07/140708092126.htm
Investigación y Desarrollo. "Advantages of standardizing diabetes treatments." ScienceDaily. www.sciencedaily.com/releases/2014/07/140708092126.htm (accessed October 25, 2014).

Share This



More Health & Medicine News

Saturday, October 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) — IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) — A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) — The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) — An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins